18th-ebf-open-symposium-kcasbio November 18 - November 20

Join KCAS Bio at the 18th EBF Open Symposium, taking place in Barcelona, Spain, on November 18-20. This event will bring together scientists from around the globe to discuss a broad array of bioanalytical topics. With the theme “Tuning in to Tomorrow,” The EBF Open Symposium will include strategic presentations…

act-46th-annual-meeting-kcasbio November 16 - November 19

KCAS Bio will participate in the ACT 46th Annual Meeting, taking place November 16-19 in Phoenix, Arizona. The ACT Meeting gathers the toxicology community for four days of scientific exchange, networking, and professional development. With a strong focus on applied toxicology, the meeting features a robust scientific program, including symposia,…

amp-2025-annual-meeting-kcasbio November 11 - November 15

KCAS Bio will participate in the AMP 2025 Annual Meeting & Expo, taking place November 11-15 in Boston, MA. The AMP 2025 Annual Meeting brings together industry leaders and experts focused on advancing molecular diagnostics and precision medicine. The event covers the latest innovations in biomarker discovery, genomic testing, assay…

aaps-pharmsci-230-2025-kcasbio November 9 - November 12

KCAS Bio will participate in AAPS 2025 PharmSci 360, taking place November 9-12 in San Antonio, TX. AAPS 2025 PharmSci 360 gathers industry professionals for a conference that covers the full spectrum of drug development. Topics will cover preclinical research, bioanalytics, clinical pharmacology, formulation, manufacturing, and regulatory science. These topics…

sitc-2025-KCASBio November 5 - November 9

KCAS Bio will be participating in Society for Immunotherapy of Cancer (SITC) 2025, taking place on November 5-9 in National Harbor, MD. SITC 2025 convenes researchers, clinicians, and biopharmaceutical developers to explore the latest breakthroughs in immune-based cancer treatments. These field experts will discuss cutting-edge research and clinical needs within…

esmo-congress-2025-kcasbio October 17 - October 21

KCAS Bio will attend the ESMO Congress 2025, taking place in Berlin, Germany, on October 17-21. ESMO Congress brings together a diverse community in the oncology field to exchange knowledge, spotlight innovation, and shape the future of cancer care on a global scale. The meeting is an opportunity to connect…

NCCGAnnualMeeting_KCASBio_2025 September 22 - September 22

KCAS Bio will be attending the NCCG Annual Meeting 2025, taking place in San Francisco on September 22. This gathering, hosted by NorCal Cytometry Group, unites professionals across the scientific, regulatory, and biotech communities who are interested in the advancements in the field of flow cytometry. The annual meeting will…

metroflow-annual-meeting-KCASBio October 23 - October 23

KCAS Bio will be attending MetroFlow 2025 Annual Meeting, taking place October 23 in New York, NY. The MetroFlow 2025 Annual Meeting brings together a dedicated community of flow cytometry professionals, including core facility directors, technical experts, researchers, and service providers. As such, this gathering provides a collaborative environment to…

NLSDays-KCASBio October 13 - October 14

KCAS Bio will be participating in Nordic Life Science Days (NLSDays) 2025, taking place October 13-14 in Gothenburg, Sweden. The conference focuses on early-stage drug development, partnerships, and innovation within the life sciences sector. Hosted by SwedenBIO, NLSDays brings together top scientists and business developers from across Europe to explore…

immunogenicity-bioassay-summit-KCASBio October 7 - October 10

KCAS Bio will be participating in the Immunogenicity & Bioassay Summit 2025, taking place October 7-10 in Alexandria, VA. This annual summit, hosted by the Cambridge Healthtech Institute, brings together leaders in immunogenicity assessment, bioassay development, and translational science to explore emerging strategies in drug development. With focused tracks on…

Soluble vs. Cellular Biomarkers: Strategic Considerations for Bioanalytical Assays in Drug Development Blogs
Read article Soluble vs. Cellular Biomarkers: Strategic Considerations for Bioanalytical Assays in Drug Development

In the ever-evolving landscape of drug development, biomarkers have emerged as critical tools for the mechanism of action, early proof of mechanism, safety, predictive, efficacy, and monitoring treatment response. As the field advances, two major classes of biomarkers have come to the forefront: soluble biomarkers and cellular biomarkers. While…

APA-2025-KCASBio October 6 - October 8

Join KCAS Bio at Applied Pharmaceutical Analysis (APA) 2025, taking place October 6-8 in Cambridge, Massachusetts. This scientific meeting, hosted by The Boston Society features three days of expert-led workshops on Regulated Bioanalysis, Discovery Bioanalysis, and Mechanistic ADME. The Mechanistic ADME track explores innovative topics such as PROTACs, molecular glues,…